Abstract:Background: Presently, viral vector used in gene therapy has immunogenicity to the body and has a potential to infect, so it has limitation to be used in clinic. Onjective: To construct the non-pathogenic recombinant adeno-associated virus (AAV) simultaneously carrying human vascular endothelial growth factor 165 (hVEGF 165) gene and green fluorescent protein (GFP) label, and assess its biological activity and function by infecting rabbit bone marrow mesenchymal stem cells (BMSCs) in vitro. Design, Time and Setting: An open experiment was performed at the Laboratory of Virus of Shanxi Provincial Center for Disease Control and Prevention between March and November 2007. Materials: BMSCs were harvested from mature New Zealand rabbits after primary culture by the experimenter. Human umbilical vein endothelial cells (HUVECs) were harvested from infant umbilical cores of healthy parturients. Informed consents were obtained from parturients. Methods: Plasmid pAAV-hVEGF 165-IRES-hrGFP was constructed by hVEGF 165 segments amplified from plasmid pUC18-hVEGF165 carrying hVEGF 165 gene. The recombinant expression plasmid pAAV-hVEGF165-IRES-hrGFP was co-transfected into AAV-293 cells with pAAV-Helper and pAAV-RC for recombinant AAV replication and package through homologous recombination. In vitro cultured rabbit BMSCs were infected with this recombinant virus. Main Outcome Measure: The efficiency of AAV packaging was monitored under a fluorescent microscope and the virus titer was measured through infecting AAV-HT1080, and the recombinant virus was verified by polymerase chain reaction (PCR) of the exogenous interest gene. Through infecting rabbit bone marrow mesenchymal stem cells in vitro, the infection efficiency was detected. The expression of VEGF 165 in BMSCs was detected by enzyme linked immunosorbent assay (ELISA), and its biological activity was assessed by angiopoiesis experiment of HUVECs in vitro. Results: The hVEGF 165 gene was successfully amplified and recombinant pAAV-hVEGF 165-IRES-GFP was verified by double digestion. The system provided a high packing ratio of more than 95% and the purified recombinant virus had a high titer of 5.5 × 10 11 vp/mL. The recombinant virus was confirmed by exogenous human VEGF 165 gene PCR. The rAAV-VEGF 165-GFP could infect rabbit BMSCs at a ratio of 40%. With rAAV-VEGF165-GFP infection, the expression of VEGF 165 in the conditional medium was detected by ELISA at a concentration of (85.58±5.37) μ g/L 72 hours after infection. HUVECs became extended, deformed, pullulation, cross-linking and showing tube-shape affected by VEGF protein. Conclusion: The non-pathogenic rAAV-hVEGF 165-GFP simultaneously carrying hVEGF 165 and GFP label is successfully constructed, with the ability of infecting rabbit BMSCs to efficiently express hVEGF 165, and hVEGF 165 expressed in BMSCs has a satisfying biological activity of stimulation of HUVECs proliferation.

[Construction of Human Gax Gene Eukaryotic Expression Vector and Its Expression in Vascular Smooth Muscle Cells].

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Construction and Identification of Human Growth Arrest-Specific Homeobox Gene Recombinant Adenovirus

Construction of human eukaryotic expression plasmid vascular endothelial growth factor 165 and its expression in transfected vascular smooth muscles.

[Effects on Proliferation and Apoptosis of Serum-Induced Rabbit VSMCs by Adenovirus-Mediated Transfer of the Gax Gene].

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

Digital optical imaging of green fluorescent proteins for tracking vascular gene expression: feasibility study in rabbit and human cell models.

Effects of Human Growth Arrest-Specific Homeobox Gene Delivery on Proliferation, Migration and Cell Cycle Distribution of Vascular Smooth Muscle Cells

Construction and expression of enhanced green fluorescent protein and HGF co-expression vector

Production of Human Vascular Endothelial Growth Factor in Silkworm by Using a Recombinant Baculovirus

[Construction of Eukaryotic Expression Vector for Human Glial Derived Neurotrophic Factor and Its Expression in Spinal Cord Tissue of SD Rat].

Construction of Eukaryotic Expression Plasmids Containing Green Fluorescent Protein Gene and CYP19 WT or Its Variants

Construction of A Recombinant Vector Based on Aav Carrying Human Endothelial Nitric-Oxide Synthase Gene

[Construction of Co-Expression Plasmid Containing Tpa and VEGF165 Genes and Its Expression in VSMCs].

Construction of recombinant eukaryotic expression vector pEGFPN1-GDNF and its expression

[Construction of Recombinant Adenovirus Vector of Calcitonin Gene-Related Peptide Gene and Transfection to Neonatal Rat Cardiomyocytes].

Construction of Hbfgf Eukaryotic Expression Plasmid and Its Expression in Gingival Fibroblasts of Beagle

[Construction of VEGF Eukaryotic Expression Vector and Its Expression in Endothelial Cells and Cardiac Myocytes In-Vitro].

Construction of recombinant adeno-associated virus carrying human vascular endothelial growth factor 165 and in vitro infection of bone marrow mesenchymal stem cells

[Construction and Expression of Retroviral Vector Encoding Enhanced Green Fluorescent Protein]

Construction of vector SM22α-PAC-IRES2-EGFP used for purification of smooth muscle cells and its expression in mouse embryonic stem cells